Research at Fox Chase »Research Areas »Research Programs

Researcher	Research Area
Angela R Bradbury, MD	Director, Breast and Ovarian Cancer Risk Assessment Primary research focus areas are ethical dilemmas in the cancer prevention field and predictive genetic testing Research on how and when parents communicate their BRCA (breast cancer gene) mutation status to their children and the impact of early communication of genetic risk on children's health behaviors
Carolyn Y. Fang, PhD	Program Leader Director, Cancer Prevention and Control Program Associate Professor Education, risk assessment, and evaluation of screening and prevention programs for individuals with a family history of cancer through The Margaret Dyson Family Risk Assessment Program (FRAP) Education directed towards women with benign breast disease through The Benign Breast Registry to Assess Valid Endpoints (BeBrave) Program
Veda N Giri, MD	Director, Prostate Cancer Risk Assessment Assistant Professor in Cancer Prevention and Control, Medical Oncology, and Clinical Genetics Awarded the Special Interest Award by ACS to investigate the role of DNA mismatch repair defects in prostate cancer susceptibility Ongoing research into the genetic, molecular and proteomic pathways involved in cancer susceptibility, especially prostate cancer
Andrew K Godwin, PhD	Director, Clinical Molecular Genetics Laboratory Director, Biosample Repository Co-Leader, Women’s Cancer Program Co-PI, Specialized Program of Research Excellence in Ovarian Cancer (SPORE) Member, Department of Medical Oncology Primary focus directed at improving the understanding of the etiology of several types of cancer and assessing molecular-targeted therapies for the treatment of these diseases. Studies primarily involve three different types of cancer, gastrointestinal stromal tumors (GISTs), ovarian, and breast
Stuart R Lessin, MD	Director, Dermatology-Cutaneous Oncology Program Professor Clinical research program established to investigate various aspects of cutaneous oncology. Skin cancers under investigation include melanoma, cutaneous T-cell lymphoma, and non-melanoma skin cancer (basal/squamous cell carcinoma)
Mary E Ropka, PhD, RN, FAAN	Assistant Professor Research focuses on understanding the diverse and multiple decisions that individuals and families face when dealing with hereditary cancer risk (HCR)
Eric A. Ross, PhD	Senior Director, Academic Informatics Assistant Professor Primary focus involves the use of information technology and quantitative methods in support of clinical, population and basic research
David S Weinberg, MD, MSc	Chair, Department of Medicine Research focus on cancer prevention, especially for patients who are at average risk for gastrointestinal cancers.